Equities

Akums Drugs and Pharmaceuticals Ltd

Akums Drugs and Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)851.90
  • Today's Change1.90 / 0.22%
  • Shares traded44.89k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 09:33 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income(453)1,503(1932)
Depreciation/depletion1,2561,128947
Non-Cash items4,3054495,367
Cash taxes paid, supplemental624971548
Cash interest paid, supplemental43440489
Changes in working capital(129)(1314)(4064)
Total cash from operations4,9791,766319
INVESTING
Capital expenditures(3114)(3288)(2576)
Other investing and cash flow items, total(190)241228
Total cash from investing(3304)(3047)(2348)
FINANCING
Financing cash flow items(434)(404)(89)
Total cash dividends paid------
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net(646)1,6502,450
Total cash from financing(1080)1,2452,360
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash594(35)331
Net cash-begin balance/reserved for future use516551221
Net cash-end balance/reserved for future use1,111516551
SUPPLEMENTAL INCOME
Depreciation, supplemental1,2561,128947
Cash interest paid, supplemental43440489
Cash taxes paid, supplemental624971548
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.